The researchers discovered that small-molecule GLP-1 drugs significantly reduced how much dopamine, a neurotransmitter thats commonly associated with reward-motivated behaviors, was released, essentially changing the animals perception of how rewarding that food is. Gler hopes that his teams discovery can help guide future efforts in designing GLP-1 drugs that target specific parts of the brain, such as the reward center
69 This condition is poorly understood even though one epidemiologic study concluded that it occurs in up to 2.7% of the adult U.S
Full text: Pizzorno J
Revamp Your Life
The in vitro culture of the NCI-H716 human intestinal cell line revealed that nutrients such as palmitic acid, oleic acid and meat hydrolysates can stimulate GLP-1 secretion in a dose-dependent manner (31), however, long-term exposure to long-chain saturated fatty acids such as palmitic acid can lead to ceramide accumulation, caspase-3 activation, and increased DNA fragmentation leading to cell death in GLP-1- producing cells (32)
Beyond weight loss, tirzepatide also demonstrated significant improvements in fasting insulin, blood pressure, lipid profiles, and overall glycaemic control, reinforcing its potential role in long-term metabolic health management
